CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
企業コードCBLL
会社名Ceribell Inc
上場日Oct 11, 2024
最高経営責任者「CEO」Chao (Xingjuan)
従業員数281
証券種類Ordinary Share
決算期末Oct 11
本社所在地360 N. Pastoria Avenue
都市SUNNYVALE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94085
電話番号18004360826
ウェブサイトhttps://ceribell.com/
企業コードCBLL
上場日Oct 11, 2024
最高経営責任者「CEO」Chao (Xingjuan)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし